Atlas Trials

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Clinical trial NCT02102022 · TERMINATED

Trial details

NCT number
NCT02102022
Sponsor
Polaris Group
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric CancerColorectal Cancer
Start date
2014-11-01
Primary completion
2020-02-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.